Background/Aims: Genetic or nutritional deficiencies in homocysteine (Hcy)metabolism lead to the accumulation of Hcy and its metabolites in the blood. This can lead to hyperhomocysteinemia (HHcy), which is an independent risk factor for cardiovascular disease. Studies have shown that HHcy leads to endothelial dysfunction, a hallmark of atherosclerosis, which may explain this link. The precise mechanism remains unclear, but a strong possibility is excessive HHCy-induced autophagy. Autophagy has been better studied in ischemia/ reperfusion (I/R) injuries, and previous work showed that Oxymatrine (OMT), a quinolizidine alkaloid, protects cells against myocardial I/R injury by inhibiting autophagy. The aim of this study was to determine whether OMT inhibits autophagy in HHcy. Methods: Autophagy in HUVEC cells treated with Hcy in the presence and absence of OMT was visualized bytransmission electron microscopy and the degree was determined by western blotting and qRT-PCR. Small interfering RNA (siRNA)was used to determine the efficiency of Macrophage migration inhibitory factor (MIF) inhibition. Cell apoptosis wasdetected by western blotting and flow cytometric analysis. Results: OMT inhibited autophagy, MIF, and mTOR in HUVECs during Hcy exposure, depending on the dose. siRNA-mediated MIF knockdown decreased Hcy-induced autophagy, while administration of 3-methyladenosine and rapamycin showed that they also 
Introduction
Atherosclerosis is a complex, multi-cellular inflammatory disease and the leading cause of morbidity worldwide. Atherosclerosis results from multiple processes, including endothelial dysfunction, vascular smooth muscle cell proliferation, inflammation, oxidative stress, and matrix alteration. Among these, endothelial dysfunction is pivotal in the initiation and development of atherosclerosis [1, 2] . Homocysteine (Hcy)is an independent risk factor for atherosclerosis, and is thought to contribute to endothelial dysfunction through Hcy-induced cell injury [3] . The mechanism for Hcy-induced endothelial cell injury is not clear, but several studies have demonstrated that it involves autophagy [4] . Autophagy is a catabolic pathway for bulk turnover of proteins and organelles via a lysosomal degradation process, and normally functions to protect cells by removing protein aggregates and damaged organelles. Several studies suggest that autophagy is an adaptive response to avert apoptosis during nutrient-limiting conditions, such as in the presence of high levels of Hcy, ischemia or hypoxia [5] [6] [7] . However, up-regulation of autophagy during reperfusion may be detrimental because autophagy can lead to degradation and excessive self-digestion of necessary cellular compartments [8] . For example, cells damaged by Hcy exhibit features of autophagic/lysosomal cell death, including greater degradation of LC3-I to LC3-II and the cytoplasmic autophagic vacuoles. Inhibition of autophagy may therefore help reduce ischemic injury and enhance cell survival in vivo [9] . This suggestion is supported by the fact that inhibition of H/R-induced autophagy by 3-methyladenine (3-MA) promotes cardiac myocyte survival [10] .
Oxymatrine (OMT), a type of quinolizidine alkaloid derived from the herb Sophora flavescens Ait., is commonly used in traditional Chinese medicine and exhibits a variety of pharmacological properties (Fig. 1 ). It has been used for the treatment of inflammatory diseases, various types of cancer, heart injury induced by myocardial ischemia [11] , hypertension [12] , and septic shock [13] , and previous studies have shown that it is effective against ischemia and reperfusion injury [14] . The effective mechanisms may be the inhibition of oxidative stress, inflammation, and induction of apoptosis. For example, in anticancer therapies OMT can accelerate apoptosis by inhibiting autophagy [15, 16] . However, the effect of OMT on cell autophagy in various stress conditions has not been investigated to date, especially HHcy. In this study, we used HUVECs treated with Hcy to demonstrate that OMT protects against Hcy-induced injury, and that the molecular mechanism involves OMTmediated inhibition of excessive autophagy. This study not only identifies a novel mechanism of OMT, but also provides an impetus for research and development of its therapeutic use in the treatment of cardiac diseases.
Materials and Methods

HUVECs culture
HUVECs derived from humans were obtained from the American Type Culture Collection (ATCC, Rockville, MD). The HUVECs were cultured in DMEM supplemented with 10% FBS, 100 μ/mL penicillin, and 100 μ/mL streptomycin, and maintained in a humidified atmosphere of 5% CO 2 at 37°C. After culture with the serum-free medium for 48 hours, the cells were pretreated with various concentrations (2, 4, 8μM) of OMT before exposure to 500μM of homocysteine. The final concentration of DMSO was less 
Assessment of HUVECs viability by MTT assay
The viability of the HUVECs was measured using an MTT Cell Proliferation Assay Kit, according to the manufacturer's instructions. After Hcy exposure, MTT was added to incubate for 4 h at 37°C and solubilized with 150μL DMSO. The absorbance was measured by a microplate reader at 490 nm. Cell viability was measured as a percentage, where: Viability (%) = (OD of Assay -OD of Blank) / (OD of control -OD of blank) × 100%.
Transmission electron microscopy (TEM)
TEM is the most reliable approach for monitoring autophagy and was used in this study. The HUVECs were cultured in 6 cm dishes with 500μM of Hcy for 48 h.Cells were collected and fixed. The ultrathin 50nm sections were cut by use of an ultramicrotome, stained with2% (w/v) uranyl acetate and lead citrate, then examined with a Hitachi 600 electron microscope (Hitachi, Japan).
LDH activity
To determine the amount of cell injury induced by Hcy, LDH activities in the culture media were measured using a Lactate Dehydrogenase Activity Assay kit according to the manufacturer's instructions.
Mitochondrial and cytosolic fractionation
We determined the release of pro-apoptotic factors from mitochondria to cytosol using western blot. We isolated the mitochondria using a Mitochondria Isolation Kit (Beyotime Institute of Biotechnology, China). Briefly, cells were incubated in 100μL ice-cold mitochondrial lysis buffer on ice for 10min. The cell suspension was then placed into a glass homogenizer and homogenized for 30 strokes using a tight pestle on ice. The homogenate was centrifuged at 600g for 10 min. at 4°C to remove nuclei and unbroken cells. Then, the supernatant was collected and centrifuged again at 12000g for 30 min. at 4°C to obtain the cytosolic (supernatant) and mitochondrial (deposition) fraction. Samples of cytosol and mitochondria were then dissolved in a lysis buffer, and proteins were subjected to western blot for the analysis of cytochrome c (cyto C).
RNA extraction and quantitative real-time polymerase chain reaction (qRT-PCR)
The expression levels of Atg5 and Beclin 1 genes were determined by qRT-PCR. Briefly, total RNA was extracted from HUVECs with RNAiso Plus, according to the protocol of the manufacturer (Takara, Dalian, China). 500 ng of total RNA was used to generate cDNA by using a Primescript RT reagent kit from Takara. The resulting cDNAs were quantified by on an ABI 7500 Real-Time PCR System (Applied Biosystems) using the following primers: Atg5: 5′-AGTGGAGGCAAC AGAACC-3′ (forward) and 5′-GACACGAACTGGCACATT-3′ (reverse-forward); Beclin 1: 5′-GGCAGTGGCTCCTATT-3′ (forward) and 5′-GGCGTGCTGTGCTCT GAAAA-3′. The data were normalized to β-actin transcript levels using 5′-CTGTATGCC TCTGGTCGTAC-3′ (forward) and 5′-TGATGTCACGCACGATTTCC-3′ (reverse-forward) primers. Expression was calculated using the ΔΔC t method.
Small interference RNA transfection MIF-specific small interfering RNA (siRNA) (Dharmacon, Perbio Science, Brebieres, France) were transfected into HUVECs using TurboFect transfection reagent (#0531; Thermo scientific, USA), according to the manufacturer's recommendations. HUVECs grown to 60% to 70% confluence were starved with 2% fetal bovine serum in Dulbecco'smodified Eagle's medium (DMEM) for 24 h, transfected with Turbofect transfectionreagent for 4-6 h, at which point fresh medium were replaced. The cells were harvested 48h after transfection.
Flow cytometric analysis of apoptosis
To assess apoptosis, an annexin V-FITC/PI staining kit was used according to the manufacturer's protocol. The HUVECs were collected following digestion with 0.25% trypsin, washed twice with PBS, and suspended in 400 μl binding buffer. Cell suspensions were stained with 5 μl Annexin V-FITC and 10 μl PI, according to the manufacturer's protocol, prior to being subjected to flow cytometry analysis in a FACSortFlow Cytometer (BD Biosciences). The data were analyzed with the WinMDI software (v2.9, bio-soft Net).
Measurement of caspase-3 activity in HUVECs
Caspase-3 activity was measured using a commercially available caspase-3 assay kit from Sigma, according to the manufacturer's instructions. For the assay, the fluorogenic ubstrates for caspase-3 were labelled with the fluorochrome AMC (7-aminomethyl coumarin). AMC was released from these substrates on cleavage by caspase-3. The activity of caspase-3 was determined by monitoring the fluorescence produced by free AMC using a GloMax 20/20n Luminometer (Promega, Madison, WI, USA) at 360/460 nm.
Western blot analysis
Western blot analysis was performed as previously described with a small modification. The HUVECs were treated with the conditions as above indicated. To prepare the whole cell lysate, the cells were harvested and lysed with RIPA buffer for western blot analysis after protein quantification with a BCA assay kit (PIERCE, Rockford, USA). Equal amounts of denatured protein samples were subjected to SDS-PAGE and then transferred to Immobilon-PSQ PVDF membranes. The membranes were blocked in 5% non-fat milk and incubated with primary antibodies followed by exposure to the respective HRP-conjugated secondary antibodies. Immunoreactive bands were visualized using ECL (enhanced chemiluminescence) reagents and digitalized by scanning. The level of each protein was quantified using the software of image J (NIH, Bethesda, MD, USA), followed by densitometric analysis of the ratio of each target protein to the β-actin band.
Drugs and reagents
Caspase-3 assay kits, HEPES, and dimethyl sulfoxide (DMSO) were purchased from Sigma (St. Louis, MO, USA). Oxymatine was dissolved in DMEM. Antibodies against cleaved caspase-3, LC3, SQSTM1 (P62), cytochrome c and Bax were purchased from Cell Signaling Technology (Danvers, MA, USA). Antibodies against MIF were purchased from Abcam (Cambridge, UK). Antibodies against phospho-mTOR, Beclin-1, Bcl-2, and Atg5 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies against β-actin, anti-rabbit secondary antibody, and anti-mouse secondary antibody, were purchased from Wuhan Boster Biotechnology Limited Company (Wuhan,China). Dulbecco's modified Eagle's medium (DMEM) and fetal bovine serum (FBS) were purchased from Gibco Laboratories (Carlsbad, CA, USA). The annexin V -FITC Apoptosis Detection kit was purchased from Dojindo Molecular technologies, Inc. (Shanghai, China). Lipofectamine™ 2000 was obtained from Invitrogen Biotechnology (Camarillo, USA). siRNAs were obtained from Shanghai Genepharma Co., Ltd. (Shanghai, China). All other chemicals and regents were obtained from local agencies.
Statistical analysis
All assays were repeated at least three times independently. All data were expressed as the mean ± standard deviation (S.D.), and analyzed with SPSS 18.0 statistical software. Differences between groups were determined with a one-way analysis of variance (ANOVA) followed by a Student-Newman-Keuls test. A value of P˂0.05 was considered statistically significant.
Results
OMT alleviates Hcy-induced injury
We assessed cell viability in every group by MTT. As shown in Fig. 2 , exposure of HUVECs to Hcy resulted in a significant decline in cell viability. In contrast, OMT (2, 4, 8μM) treatment increased the survival rate of HUVECs that were exposed to Hcy, at a rate depending on the concentration of OMT (Fig. 2A) . Since lactate dehydrogenase (LDH) leakage is frequently used as a marker of cellular damage, HUVEC injury was assessed by measuring LDH activity in the culture medium after incubation with Hcy. LDH leakage increased in the Hcy-treated group compared with the control group, but decreased significantly in the Hcy group that was also (Fig. 2B ). These findings indicated that OMT can promote cell survival and reduce cell damage in HUVECs with exposure to Hcy.
OMT inhibits autophagy in HUVECs subjected to Hcy
Autophagy, a lysosomal degradation process for cytoplasmic constituents, is known to be activated when HUVECs are exposed to Hcy. To investigate whether OMT affects autophagy in such HUVECs, and to measure cytological changes in autophagic cells, we examined the intracellular morphologic changes of HUVECs via transmission electron microscopy (TEM). As shown in the electron micrographs, autophagic vacuoles, which contain sub-cellular materials, were observed in Hcy-treated HUVECs (Fig. 3A) . The size of the autophagic vacuoles containing [17] . As shown in Fig. 3C , LC3-II was upregulated in HUVECs during Hcy exposure, while OMTinhibited the expression of LC3-II. To further investigate the effects of OMT on autophagy, qRT-PCR and western blot were used to determine the expression levels of the autophagy-related genes Atg 5 and Beclin-1. In Hcy exposed HUVECs, levels of Atg 5 and Beclin-1 mRNA and protein were increased, but OMT treatment reduced the expression of Atg 5 and Beclin-1 (Fig. 3D, E, F, G) . These results indicate that OMT inhibits Hcy-induced autophagy in HUVECs, with the magnitude of the effect depending on the concentration. 
OMT inhibits Hcy-induced autophagy through the MIF /mTOR pathway
Accumulating evidence suggests that MIF/mTOR signaling is involved in the regulation of autophagy [18] . However, whether this signaling pathway is mediated by OMT in HUVECs exposed to Hcy has not been assessed. Thus, we next investigated the underlying molecular mechanisms responsible for the inhibition of Hcy-induced autophagy under OMT treatment. We first examined whether OMT could regulate the MIF/mTOR signaling pathway. As shown in Fig. 4A , B, the expression of MIF markedly increased and the phosphorylation of mTOR significantly decreased in HUVECs with exposure to Hcy, indicating that OMT could inhibit Hcy-induced MIF. Reduced phosphorylation levels of mTOR were also observed after OMT treatment, depending on the concentration.
To further assess the function of MIF, MIF was knocked down using MIF-specific siRNA. The knockdown efficiency shown in Fig. 4 indicates that MIF knockdown significantly reduced autophagy (Fig. 4C, D, E) . In addition, knockdown of MIF significantly reduced the phosphorylation of mTOR subjected to Hcy (Fig. 4) . Taken together, these findings suggest that OMT inhibits autophagy through the MIF/mTOR pathway.
Hcy induced apoptosis is related to autophagy
To confirm our hypothesis that inhibition of autophagy is a mechanism through which OMT protects cells exposed to Hcy, we used 3-methyladenine (3-MA), a phosphoinositide3-kinase inhibitor that inhibits autophagy before the formation of autophagosomes, and a classical autophagy sensitizer, rapamycin, which is generally used to induce autophagy. The levels of LC3-II and cleaved caspase-3 expressions were decreased by pretreatment 
with 3-MA in the Hcy-treated group (Fig. 5A, B) . Pretreatment with rapamycin significantly increased LC3-II and cleaved caspase-3 expressions, indicating that rapamycin could induce apoptosis, which is related to autophagy.
OMT decreases Hcy-induced apoptosis in HUVECs
To investigate the effect of OMT on Hcy-induced apoptosis in HUVECs, we first examined early apoptosis by flow cytometry, following annexin V-FITC and propidium iodide (PI) dual labeling. We found that OMT (2, 4, 8μM) reduced Hcy-induced apoptosis (Fig. 6E) .
To further assess how OMT protects against apoptosis in HUVECs, we examined the mitochondrial cell-death pathway and measured the release of cytochrome c from the inner mitochondrial space. As depicted in Fig. 6A , B, OMT inhibits Hcy-induced cytochrome c release into the cytosolic fraction. The release of cytochrome c from the mitochondria triggers downstream activation of caspase-9, which, in turn, cleaves caspase-3, resulting in cell death (Fig. 6C) . Further analysis of caspase-3 activity in the lysates of HUVECs indicated that OMT decreased Hcy-induced caspase-3 activity (Fig. 6F, G) , depending on the concentration.
The expression levels of the apoptotic marker cleaved caspase-3 and apoptosis-related proteins, such as Bcl-2 and Bax, were also examined using western blot. OMT decreased the expression of cleaved caspase-3 during Hcy exposure. The Bcl-2/Bax ratio also decreased in the HUVECs exposed to Hcy, and this reduction was greatly attenuated to OMT treatment (Fig. 6D) .
Discussion
Atherosclerosis is a chronic inflammatory disease affecting medium-to large-sized arteries.Its pathogenesis is coordinated among smooth muscle cells,macrophages, and endothelial cells. Endothelial cells are the first to experience the impact of stimuli and physiological factors from their surroundings. Thus, injury of the vascular endothelium isknown to be an initial step in the pathogenesis of atherosclerosis [19] . Elevated blood levels of Hcy are an independent risk factor for cardiovascular disease. Hcyis an important intermediate in one-carbon metabolism that involves the conversion of methionine to cysteine, and folate interconversions. Deficiencies in these pathways lead to the accumulation of Hcy and its metabolites in the blood, which causes endothelial dysfunction (endothelial cell injury and autophagy) [20] [21] [22] .
Macrophage migration inhibitory factor (MIF), a multipotent cytokine that is secreted by T lymphocytes, macrophages, endothelial cells, and other inflammatory cells, mediates inflammation and modulates metabolism [23, 24] . MIF plays pleiotropic roles in acute and chronic inflammatory diseases and cardiovascular diseases, such as rheumatoid arthritis, atherosclerosis, and cardiovascular diseases [25, 26] . MIF may mediate prolonged cardiac I/R injury by enhancing inflammatory responses. However, accumulating evidence has suggested cardioprotective roles for MIF under pathological conditions, including atherosclerosis, arterial remodeling, I/R and myocardial infarction [23] . Meanwhile, an increase in MIFinduced kinase activation and phosphorylation may accelerate atherosclerosis by activating the ERK, AMPK and JNK signaling cascades [27, 28] . Surprisingly, recent studies have revealed that MIF can inhibit autophagy [9, 29] . The present study showed that knockdown MIF partially inhibited autophagy in HUVECs exposed to Hcy [30] .
The mammalian target of rapamycin (mTOR) is a serine/threonine protein kinase that regulates survival, cell growth, angiogenesis, gene expression, and synaptic functions in various cellular processes. mTOR belongs to the phosphatidylinositol3-kinase (PI3K) protein family. Recently, there has been growing evidence that mTOR is an important downstream mediator that regulates autophagy [30] [31] [32] . Moreover, activation of MIF/mTOR downstream signaling is an important signaling pathway that stimulates cell growth and proliferation, and provides cardio protection by reducing autophagy in myocardial I/R and suppressing the inflammatory response [9] . At the same time, mTOR may have control cell death through (Fig. 7) . Autophagy is characterized by the formation of double-membrane vesicles called autophagosomes, which sequester the cytoplasmic structures targeted for destruction. It is an evolutionarily conserved catabolic process in which intracellular membrane structures package protein complexes and organelles to degrade and to renewthese cytoplasmic components [32] . Normally, autophagy is a homeostatic mechanism for maintaining cell structure and function by providing energy and nutrients through the lysosomal degradation of cytoplasmic constituents, but excessive autophagy can be induced by stresses, such as nutrient depletion, inflammation, high-fat diet and oxidative stress.
Numerous studies have revealed that high levels of Hcy contribute to autophagy [5] , which is linked to atherosclerosis, although its role in endothelial cell damage remains unclear.Some evidence suggests that autophagy promotes cell survival through its baseline mechanism of recycling cellular components, but autophagy may also promote cell death through excessive degradation of essential cellular constituents or activate the apoptotic cascade. The latter view is supported by studies showing that autophagy inhibition may decrease apoptosis [33] . Under basal conditions autophagy and apoptosis cross-regulate each other through an elaborate network of interconnections which also includes the interplay between autophagy-related proteins (ATGs) and caspases [34] .
In this study, we examined tracers of autophagy, such as expression levels of LC3-II (Fig.  3A) , Beclin-1, and cleaved caspase-3 protein. We found that they increased when HUVECs were exposed to Hcy,which suggests that Hcy exposure may induce autophagy and apoptosis. We also showed that autophagic vacuoles were present in Hcy-treated HUVECs. The size of autophagic vacuoles containing remnants of organelles was approximately 1μm in diameter. Furthermore, we observed up-regulation of ATG5 and increased apoptosis in the HUVECs exposed to Hcy. These effects were reduced by OMT.
In order to clarify the relationship between apoptosis and autophagy, we utilized a phosphoinositide3-kinase inhibitor that arrests autophagy before the formation of autophagosomes, 3-methyladenine (3-MA). We also used rapamycin to induce autophagy. During treatment with OMT, the level of the LC3-IIprotein decreased significantly for cells exposed to Hcy (Fig 3A) . The effect of OMT was similar to that of 3-MA. We then used rapamycin to confirm that autophagy-induced apoptosis is a primary event in the secondary damage in HUVECs. As far as we know, this is the first study demonstrating that OMT protects HUVECs from Hcy by inhibiting autophagy. In conclusion, OMT significantly reduces the extent of damage following Hcy exposure and improves the survival of HUVECs. This protective role of OMT is related to the inhibition of excessive autophagy, which is related to the activation of the downstream signaling pathways MIF/mTOR. Our study demonstrates that therapeutic strategies using OMT may be suitable for recovery from Hcy exposure. 
